Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Reexamination Certificate
2007-05-29
2007-05-29
Whiteman, Brian (Department: 1635)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
Reexamination Certificate
active
10800256
ABSTRACT:
The present invention discloses lentogenic viral strains useful in the treatment of cancer. A preferred viral strain of Newcastle Disease Virus (NDV) is specifically characterized in terms of biological activities. The present invention further discloses treatment of cancer by application of a clonal NDV strain to tumors. Another feature of the invention is the use of at least one isolated viral glycoprotein or a subunit or analog thereof or of an isolated polynucleotide encoding the same for the treatment of cancer.
REFERENCES:
patent: 5118502 (1992-06-01), Glisson et al.
patent: 5602023 (1997-02-01), Csatary
patent: 5733556 (1998-03-01), Schrier et al.
patent: 5762938 (1998-06-01), Paoletti et al.
patent: 6464984 (2002-10-01), Audonnet et al.
patent: 6719979 (2004-04-01), Peeters et al.
patent: 7056689 (2006-06-01), Lorence et al.
patent: 2003/0044384 (2003-03-01), Roberts et al.
patent: 2003/0077819 (2003-04-01), Groene et al.
U.S. Appl. No. 60/290,051.
David Tzadok et al., “The effect of a mesogenic and a lentogenic newcastle disease virus strain on burkitt lymphoma daudi cells” J. Cancer Res. Clin. Oncol. 1995, vol. 121, pp. 169-174 (1995).
Schirrmacher et al. “Antitumor effects of newcastle disease virus in vivo: local versus systemic effects” International Journal of Oncology 2001, vol. 18, pp. 945-952 (2001).
Phuangsab et al., “Newcastle disease virus therapy of human tumor xenografts: Antitumor effects of local or systemic administration,”Cancer Ltrs., 172: 27-36 (Oct. 2001).
Freeman et al., “Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme,”Molecular Therapy, pp. 1-8 (Nov. 2005).
Irving Charles
Panet Amos
Zakay-Rones Zichria
Theravir Management L.P.
Whiteman Brian
Winston & Strawn LLP
Yissum Research Development Company of the Hebrew University of
LandOfFree
Compositions and methods for treatment of cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for treatment of cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for treatment of cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3759993